BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8651034)

  • 1. The use of DAV (DTIC, ACNU and VCR) and natural interferon-beta combination therapy in malignant melanoma.
    Nagatani T; Ichiyama S; Onuma R; Miyazawa M; Matsuzaki T; Miyagawa K; Baba N; Uchiyama M; Nakajima H
    Acta Derm Venereol; 1995 Nov; 75(6):494. PubMed ID: 8651034
    [No Abstract]   [Full Text] [Related]  

  • 2. Changes in immunological parameters after combination adjuvant therapy with intravenous DTIC, ACNU, and VCR, and local injection of IFN-beta (DAV + IFN-beta therapy) into malignant melanoma.
    Umeda T; Aoki K; Yokoyama A; Ohara H; Hayashi O; Tanaka K; Nishioka K
    J Dermatol; 1998 Sep; 25(9):569-72. PubMed ID: 9798342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local injection of interferon beta in malignant melanoma of the esophagus as adjuvant of systemic pre- and postoperative DAV chemotherapy: case report with 7 years of long-term survival.
    Kawada K; Kawano T; Nagai K; Nishikage T; Nakajima Y; Tokairin Y; Ogiya K; Tanaka K; Iwai T
    Gastrointest Endosc; 2007 Aug; 66(2):408-10. PubMed ID: 17643724
    [No Abstract]   [Full Text] [Related]  

  • 4. Two cases of malignant melanoma of the toe developed skin ulcers following local injection of natural beta-interferon.
    Kurashige Y; Irisawa R; Abe N; Saito M; Tsuboi R
    J Dermatol; 2012 Dec; 39(12):1037-8. PubMed ID: 22758215
    [No Abstract]   [Full Text] [Related]  

  • 5. Complete remission of metastatic clear cell sarcoma with DAV chemotherapy.
    Fujimoto M; Hiraga M; Kiyosawa T; Murakami T; Murata S; Ohtsuki M; Nakagawa H
    Clin Exp Dermatol; 2003 Jan; 28(1):22-4. PubMed ID: 12558622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Malignant melanoma in Japan: unique distribution and effect of DAV chemoimmunotherapy (part II)].
    Ishihara K; Hayasaka K; Ikeda S; Terakado T; Kukita A; Seki Y; Jimbow K; Suzuki M
    Gan To Kagaku Ryoho; 1984 Mar; 11(3):467-73. PubMed ID: 6703721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case report of anorectal malignant melanoma showing a complete response after DTIC/ACNU/VCR therapy].
    Sasaki S; Kojima T; Hidemura A; Hatanaka K; Uekusa T; Ishimaru M
    Gan To Kagaku Ryoho; 2010 Oct; 37(10):1999-2002. PubMed ID: 20948273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chemotherapy of malignant melanoma].
    Ishihara K; Yamazaki N; Asano K
    Gan To Kagaku Ryoho; 1993 Aug; 20(10):1287-92. PubMed ID: 7688498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Control of multiple skin and lung metastasis of malignant melanoma by combined DAV and OK-432 chemoimmunotherapy in association with large-scale administration of indomethacin].
    Maeda K; Miura S; Kawamura M; Jimbow K
    Gan To Kagaku Ryoho; 1984 Nov; 11(11):2434-7. PubMed ID: 6497401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New combination chemotherapy for malignant melanoma--PAV(peplomycin, ACNU, VCR) therapy].
    Ikeda S; Tajima K; Miyasato H; Terakado T; Suzuki T; Miura T
    Gan To Kagaku Ryoho; 1983 Oct; 10(10):2198-204. PubMed ID: 6194756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chemotherapy of malignant melanoma].
    Ishihara K
    Gan To Kagaku Ryoho; 1995 Jan; 22(1):23-7. PubMed ID: 7529980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Malignant melanoma in Japan: unique distribution and effect of DAV chemoimmunotherapy].
    Jimbow K; Takahashi H; Ishihara K; Hayasaka K; Kukita A; Seki Y; Ikeda S; Terakado T
    Gan To Kagaku Ryoho; 1982 Nov; 9(11):1942-9. PubMed ID: 7184382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary malignant melanoma of the esophagus treated by esophagectomy and systemic chemotherapy.
    Matsutani T; Onda M; Miyashita M; Hagiwara N; Akiya Y; Takubo K; Yamashita K; Sasajima K
    Dis Esophagus; 2001; 14(3-4):241-4. PubMed ID: 11869329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-alpha induced mania during the adjuvant treatment of malignant melanoma.
    Ni Mhaolain AM; Thakore JH
    Ir J Med Sci; 2007; 176(2):137-9. PubMed ID: 17394037
    [No Abstract]   [Full Text] [Related]  

  • 15. [Case of metastatic malignant melanoma responded to combination chemotherapy with DTIC].
    Tamura T; Miyamoto H; Harada M; Makinoya T; Yamamoto M; Miyoshi Y; Komi N
    Gan To Kagaku Ryoho; 1984 Feb; 11(2):327-32. PubMed ID: 6582806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Metastatic malignant melanoma of the urinary bladder: a case report].
    Nohara T; Sakai A; Fuse H; Imamura Y
    Nihon Hinyokika Gakkai Zasshi; 2009 Nov; 100(7):707-11. PubMed ID: 19999137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myelodysplastic syndrome following treatment of malignant melanoma with vincristine, ACNU, and dacarbazine.
    Kageshita T; Kuribayashi N; Ono T
    J Dermatol; 2000 Mar; 27(3):178-80. PubMed ID: 10774145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant melanoma treated with natural interferons alfa and beta and DAV.
    Nagatani T; Ichiyama S; Miyakawa K; Uchiyama M
    Eur J Cancer; 1992; 28A(10):1774. PubMed ID: 1389506
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapy-related myelodysplastic syndrome developed by dacarbazine, nimustine hydrochloride and vincristine sulfate (DAV) therapy for patient with malignant melanoma.
    Nitta Y; Ikeya T; Sakakibara A; Tomita Y
    J Dermatol; 2011 Feb; 38(2):164-8. PubMed ID: 21269313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amelanotic malignant melanoma of the esophagus: report of a patient with recurrence successfully treated with chemoendocrine therapy.
    Suzuki Y; Aoyama N; Minamide J; Takata K; Ogata T
    Int J Clin Oncol; 2005 Jun; 10(3):204-7. PubMed ID: 15990972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.